BioNTech SE (BNTX) posted a second-quarter net loss of 386.6 million euros compared to a net loss of 807.8 million euros, prior year. Loss per share was 1.60 euros, compared to a loss of 3.36 euros. Revenues were 260.8 million euros, compared to 128.7 million euros, last year.
BioNTech expects revenues for fiscal 2025 to be in the range of 1.7 - 2.2 billion euros, and revenue phasing primarily concentrated in the last three to four months, driving the full year revenue figure.
As part of the agreement with BMS, BioNTech expects to receive $1.5 billion in an upfront cash payment in the current year. BioNTech expects to receive $2.0 billion in total non-contingent anniversary cash payments from 2026 through 2028.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.